PT  - JOURNAL ARTICLE
AU  - Hailemariam, Maji
AU  - Zlotnick, Caron
AU  - Taft, Angela
AU  - Johnson, Jennifer E.
TI  - MOSAIC (MOthers’ AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 with Experience of Intimate Partner Violence: A pilot randomized trial study protocol
AID  - 10.1101/2022.04.14.22273885
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.14.22273885
4099  - http://medrxiv.org/content/early/2022/04/16/2022.04.14.22273885.short
4100  - http://medrxiv.org/content/early/2022/04/16/2022.04.14.22273885.full
AB  - Background Pregnancy and motherhood increase the risk for long-term exposure to physical, psychological and sexual intimate partner violence (IPV; sexual or physical violence by current or former partners). Pregnant women and mothers with children under 5 who have experienced IPV exhibit poor physical and mental health and obstetric outcomes. Depression and posttraumatic stress disorder (PTSD) are the two most common mental health consequences of IPV. There is good evidence that women with good social support have better mental health and IPV outcomes.Methods This study will develop MOthers’ AdvocateS In the Community (MOSAIC) Plus intervention for pregnant women and mothers with children under the age of 5. MOSAIC uses trained mentor mothers and has been found to reduce subsequent IPV. This study will blend the original MOSAIC intervention with principles of interpersonal psychotherapy (IPT) to address symptoms of depression, PTSD, and prevent subsequent risk of IPV. We will conduct a pilot randomized trial of the MOSAIC Plus intervention compared to the traditional MOSAIC intervention to determine its feasibility and acceptability. Study samples include focus groups (n=36), open trial (n=15), and a randomized pilot trial including 40 pregnant women and mothers with children under 5 who report current/recent of IPV and elevated symptoms of maternal depression and/or PTSD. The study’s primary outcome will be changes in maternal depressive and PTSD symptoms. Secondary outcomes will include reduction in subsequent IPV, improvement in functioning, changes in social support and effectiveness in obtaining resources.Discussion This is a formative study evaluating the feasibility and acceptability of a mentor mother intervention for pregnant women and mothers with children under 5. Promising results of this study will be used for a larger, fully-powered randomized trial evaluating the effectiveness of a mentor mother intervention in preventing subsequent IPV and reducing depressive and PTSD symptoms in this population.Strengths and limitations of this studyThe study is informed by a robust qualitative approach to intervention development that involves a series of focus group discussions.This study aims to develop an intervention that reduces future intimate partner violence, while also addressing related maternal mental health outcomes.A rigorous and reproducible design includes randomization, clear inclusion criteria, manualized treatment protocols and fidelity assessments.The study will use reliable and validated measures.Given the small sample size, results from the pilot randomized trial are underpowered to draw firm conclusions about effectiveness.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05106361Funding StatementThis study was funded by the National Institute of Mental Health (NIH/NIMH) grant number R34MH127061. The views expressed in this manuscript are those of the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence (MOSAIC Plus) study was approved by Michigan State University Biomedical IRB (#00 512720). All study staff also completed the Michigan State University Human Subject training certificate and good clinical practice (GCP) trainings. The study is also registered in www.clinicaltrials.gov under identifier # NCT05106361, date of registration 03 November 2021, https://clinicaltrials.gov/ct2/show/NCT05106361.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.